Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Annals of Clinical Microbiology and Antimicrobials|May 7, 2004
Mutation at the position 2058 of the 23S rRNA as a cause of macrolide resistance in Streptococcus pyogenesJari Jalava, Martti Vaara, Pentti Huovinen
Scandinavian Journal of Infectious Diseases|August 26, 2010
Pneumococcal serotype distribution in invasive paediatric disease in Southern Finland before the introduction of vaccineSalla Laitinen, Martti Vaara, Eeva Salo
Plos One|January 12, 2008
Bacteria, phages and septicemiaAusra Gaidelyte, Martti Vaara, Dennis H Bamford
The Journal of Antimicrobial Chemotherapy|November 18, 2017
Polymyxin derivatives NAB739 and NAB815 are more effective than polymyxin B in murine Escherichia coli pyelonephritisMartti Vaara, Timo Vaara, Carina Vingsbo Lundberg
Peptides|March 17, 2017
Structure-activity studies on polymyxin derivatives carrying three positive charges only reveal a new class of compounds with strong antibacterial activityMartti Vaara, Timo Vaara, Jonathan M Tyrrell
Antimicrobial Agents and Chemotherapy|December 25, 2002
Antimicrobial susceptibilities of Campylobacter strains isolated from Finnish subjects infected domestically or from those infected abroadHilpi Rautelin, Antti Vierikko, Marja-Liisa Hänninen, et al.
The Journal of Antimicrobial Chemotherapy|March 18, 2010
Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in miceCarina Vingsbo Lundberg, Timo Vaara, Niels Frimodt-Møller, et al.
The Heart Surgery Forum|April 24, 2008
Bartonella quintana and Bartonella pediococcus Infection after Aortic Valve ReplacementAntti Vento, Tommi Pätilä, Martti Vaara, et al.
Scandinavian Journal of Infectious Diseases|May 31, 2011
Comparative activity of tigecycline and tetracycline on Gram-negative and Gram-positive bacteria revealed by a multicentre study in four North European countriesLennart E Nilsson, Niels Frimodt-Møller, Martti Vaara, et al.
The Journal of Antimicrobial Chemotherapy|February 20, 2010
Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycinMartti Vaara, Osmo Siikanen, Juha Apajalahti, et al.
Pageof 6